Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
2020; Nature Portfolio; Volume: 26; Issue: 4 Linguagem: Inglês
10.1038/s41591-020-0805-8
ISSN1546-170X
AutoresMyriam Chalabi, Lorenzo F. Fanchi, Krijn K. Dijkstra, José G. van den Berg, Arend G. J. Aalbers, Karolina Sikorska, Marta López‐Yurda, Cecile Grootscholten, Geerard L. Beets, Pétur Snæbjörnsson, Monique Maas, Marjolijn Mertz, Vivien Veninga, Gergana Bounova, Annegien Broeks, Regina G. H. Beets‐Tan, Thomas R. de Wijkerslooth, Anja U. van Lent, Hendrik A. Marsman, Elvira Nuijten, Niels F.M. Kok, Maria Kuiper, Wieke H.M. Verbeek, Marleen Kok, Monique E. van Leerdam, Ton N. Schumacher, Emile E. Voest, John B.A.G. Haanen,
Tópico(s)Colorectal and Anal Carcinomas
Referência(s)